Market Cap (In USD)
320.95 Million
Revenue (In USD)
31.78 Million
Net Income (In USD)
-4.19 Million
Avg. Volume
1.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.85-8.53
- PE
- -
- EPS
- -
- Beta Value
- 0.374
- ISIN
- IL0011007189
- CUSIP
- -
- CIK
- 1505065
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Hadar Levy
- Employee Count
- -
- Website
- https://www.brainsway.com
- Ipo Date
- 2011-04-21
- Details
- Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
More Stocks
-
EGCO-R
-
LINVLendInvest plc
LINV
-
GMEGameStop Corp.
GME
-
MVES
-
VISAKAINDVisaka Industries Limited
VISAKAIND
-
NLY-PI
-
CLTNCOLTENE Holding AG
CLTN
-
0AAJPolyPeptide Group AG
0AAJ